191 related articles for article (PubMed ID: 19291795)
1. Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.
Kim SH; Miller FR; Tait L; Zheng J; Novak RF
Int J Cancer; 2009 Jun; 124(12):2813-28. PubMed ID: 19291795
[TBL] [Abstract][Full Text] [Related]
2. Increased chemoresistance to paclitaxel in the MCF10AT series of human breast epithelial cancer cells.
Lim SJ; Choi HG; Jeon CK; Kim SH
Oncol Rep; 2015 Apr; 33(4):2023-30. PubMed ID: 25647149
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin effects on mTOR signaling in benign, premalignant and malignant human breast epithelial cells.
Kim SH; Zukowski K; Novak RF
Anticancer Res; 2009 Apr; 29(4):1143-50. PubMed ID: 19414357
[TBL] [Abstract][Full Text] [Related]
4. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
5. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD).
Starcevic SL; Diotte NM; Zukowski KL; Cameron MJ; Novak RF
Toxicol Sci; 2003 Sep; 75(1):74-81. PubMed ID: 12805649
[TBL] [Abstract][Full Text] [Related]
6. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells.
Kuo PL; Hsu YL; Cho CY
Mol Cancer Ther; 2006 Dec; 5(12):3209-21. PubMed ID: 17172425
[TBL] [Abstract][Full Text] [Related]
8. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.
Galbaugh T; Cerrito MG; Jose CC; Cutler ML
BMC Cell Biol; 2006 Sep; 7():34. PubMed ID: 16984645
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells.
Guan L; Song K; Pysz MA; Curry KJ; Hizli AA; Danielpour D; Black AR; Black JD
J Biol Chem; 2007 May; 282(19):14213-25. PubMed ID: 17360714
[TBL] [Abstract][Full Text] [Related]
12. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
13. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
Shin I; Kim S; Song H; Kim HR; Moon A
J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
[TBL] [Abstract][Full Text] [Related]
14. Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells.
Bhandari BK; Feliers D; Duraisamy S; Stewart JL; Gingras AC; Abboud HE; Choudhury GG; Sonenberg N; Kasinath BS
Kidney Int; 2001 Mar; 59(3):866-75. PubMed ID: 11231341
[TBL] [Abstract][Full Text] [Related]
15. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
16. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1).
Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM
Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325
[TBL] [Abstract][Full Text] [Related]
17. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
18. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer.
Lin HJ; Hsieh FC; Song H; Lin J
Br J Cancer; 2005 Dec; 93(12):1372-81. PubMed ID: 16288304
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
20. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle.
Southgate RJ; Neill B; Prelovsek O; El-Osta A; Kamei Y; Miura S; Ezaki O; McLoughlin TJ; Zhang W; Unterman TG; Febbraio MA
J Biol Chem; 2007 Jul; 282(29):21176-86. PubMed ID: 17510058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
